Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $2,084 - $2,312
-22 Closed
0 $0
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $3,201 - $3,712
-40 Reduced 64.52%
22 $2,000
Q4 2022

Feb 09, 2023

SELL
$75.55 - $92.52 $6,497 - $7,956
-86 Reduced 58.11%
62 $6,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $5,073 - $5,933
-68 Reduced 31.48%
148 $11,000
Q2 2022

Aug 09, 2022

SELL
$80.52 - $93.75 $14,252 - $16,593
-177 Reduced 45.04%
216 $18,000
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $7,209 - $8,155
-90 Reduced 18.63%
393 $34,000
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $25,504 - $28,201
-320 Reduced 39.85%
483 $42,000
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $23,552 - $27,400
288 Added 55.92%
803 $70,000
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $30,856 - $34,082
-362 Reduced 41.28%
515 $47,000
Q4 2020

Feb 10, 2021

BUY
$78.07 - $94.43 $5,777 - $6,987
74 Added 9.22%
877 $83,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $246 - $273
-3 Reduced 0.37%
803 $70,000
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $23,307 - $26,236
-288 Reduced 26.33%
806 $70,000
Q1 2020

May 13, 2020

BUY
$70.67 - $99.01 $8,480 - $11,881
120 Added 12.32%
1,094 $90,000
Q4 2019

Feb 07, 2020

BUY
$84.35 - $95.37 $25,726 - $29,087
305 Added 45.59%
974 $92,000
Q3 2019

Nov 07, 2019

BUY
$85.54 - $94.26 $2,309 - $2,545
27 Added 4.21%
669 $58,000
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $10,933 - $13,456
145 Added 29.18%
642 $59,000
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $2,862 - $3,273
38 Added 8.28%
497 $48,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $3,093 - $3,444
-42 Reduced 8.38%
459 $39,000
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $31,327 - $36,237
468 Added 1418.18%
501 $43,000
Q2 2018

Aug 10, 2018

BUY
$64.91 - $73.36 $2,142 - $2,420
33 New
33 $2,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Td Ameritrade Investment Management, LLC Portfolio

Follow Td Ameritrade Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.